WOOF Petco Health & Wellness Company, Inc.
Retail-Retail Stores, NEC · Nasdaq · SEC CIK 1826470 · Fiscal year ends 01/30
Financial factors as of 2026-08-01 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-1.3%
TTM net income YoY207.3%
TTM EPS YoY200.0%
Revenue 3-yr CAGR-1.1%
Net income 3-yr CAGR-5.8%
Margins
Gross margin38.8%
Operating margin2.2%
Net margin0.5%
FCF margin4.0%
EBITDA margin5.5%
Returns
ROE2.6%
ROA0.6%
ROIC (approx.)6.6%
Asset turnover1.16x
Leverage & solvency
Liabilities / assets76.6%
Debt / equity0.50x
Current ratio0.90x
Interest coverage1.03x
Cash quality & payout
Operating cash flow / net income12.36x
Accruals ratio-6.7%
Payout ratio—
Capex / revenue2.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252026-01-31 | FY20242025-02-01 |
|---|---|---|
| Income statement | ||
| Revenue | $5.96B | $6.12B |
| Cost of revenue | $3.66B | $3.79B |
| Gross profit | $2.31B | $2.32B |
| SG&A expense | $2.18B | $2.32B |
| Operating income | $120.43M | $7.05M |
| Interest expense | $131.20M | $143.53M |
| Pretax income | $15.33M | -$109.30M |
| Income tax | $6.27M | -$7.48M |
| Net income | $9.07M | -$101.82M |
| EBITDA | $317.14M | $215.57M |
| EPS (basic) | 0.03 | -0.37 |
| EPS (diluted) | 0.03 | -0.37 |
| Weighted avg. shares (diluted) | 286.15M | 273.41M |
| Balance sheet | ||
| Cash & equivalents | $256.74M | $181.66M |
| Receivables | $45.81M | $40.42M |
| Inventory | $590.21M | $653.33M |
| Current assets | $1.02B | $973.62M |
| PP&E, net | $656.15M | $725.44M |
| Goodwill | $980.06M | $980.06M |
| Total assets | $5.17B | $5.19B |
| Current liabilities | $1.13B | $1.14B |
| Short-term debt | $4.61M | $5.35M |
| Long-term debt | $0 | $1.58B |
| Total debt | $4.61M | $1.58B |
| Total liabilities | $4.01B | $4.08B |
| Shareholders' equity | $1.16B | $1.11B |
| Net debt | -$252.13M | $1.40B |
| Cash flow statement | ||
| Operating cash flow | $314.05M | $177.67M |
| Capital expenditure | $127.10M | $127.99M |
| Free cash flow | $186.95M | $49.68M |
| Investing cash flow | -$124.56M | -$123.90M |
| Financing cash flow | -$101.75M | -$8.75M |
| Depreciation & amortization | $196.71M | $208.52M |
| Stock-based compensation | $32.65M | $50.21M |
Free plan shows the latest 2 periods; Pro shows all 7 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.